U.S. stocks edge higher after weekly jobless claims; Salesforce gains
Sharon Benzeno, Chief Commercial Officer of Adaptive Biotechnologies Corp (NASDAQ:ADPT), sold 606,402 shares of common stock on November 20 and 21, 2025, for approximately $10.1 million. The sales occurred in multiple transactions with prices ranging from $16.54 to $16.91 per share. The stock has since climbed to $20.46, representing a 48.8% surge over the past week. With a market capitalization of $3.11 billion, ADPT is now trading at 99% of its 52-week high of $20.65.
On the same dates, Benzeno also exercised options to acquire a total of 492,889 shares of Adaptive Biotechnologies common stock at prices ranging from $3.99 to $12.14, for a total value of $4.46 million. The company has demonstrated strong revenue growth of 42.57% over the last twelve months, though InvestingPro data indicates it remains unprofitable with earnings per share at -$0.53.
Following these transactions, Benzeno directly owns 296,791 shares of Adaptive Biotechnologies Corp . The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 18, 2025. InvestingPro analysis reveals ADPT has delivered a remarkable 266.67% return over the past year. Investors seeking deeper insights can access ADPT’s comprehensive Pro Research Report, one of 1,400+ available for top US equities.
In other recent news, Adaptive Biotechnologies reported impressive financial results for the third quarter of 2025. The company achieved earnings per share of $0.06, significantly surpassing the market forecast of -$0.17, resulting in a surprise of 135.29%. Revenue for the quarter reached $94 million, exceeding expectations of $60.48 million by 55.37%. These financial results highlight the company’s strong performance in recent months. While stock price movements followed the earnings announcement, the focus remains on the substantial earnings and revenue achievements. Investors and analysts are likely to take note of these developments as they consider the company’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.